Introduction
In many allergic patients, intradermal challenge with specific antigen or anti-IgE induces an immediate wheal and flare reaction which is followed, 4-8 h later, by a period of persistent swelling and leukocyte infiltration termed the late phase cutaneous reaction (1) (2) (3) (4) . Late phase reactions (LPR)1 were initially described in the skin (1, 2) . However, it is now clear that late consequences of IgE-dependent reactions, notably including infiltration of the reaction sites with blood-borne leukocytes, also occur in the respiratory tract and other anatomical locations (3, 4) . Indeed, it has been argued cogently that many of the clinically significant consequences of IgE-dependent reactions, in both the skin and the respiratory system, reflect the actions ofthe leukocytes recruited to these sites during the LPR rather than the direct effects of the mediators released at early intervals after antigen provocation (3, 4) .
Several lines of evidence support the hypothesis that the leukocyte infiltration associated with LPRs occurs as a result of mast cell degranulation. In both man and experimental animals, agents that induce cutaneous mast cell degranulation by either IgE-dependent or certain other mechanisms can also promote infiltration ofthe reaction sites with leukocytes (1) (2) (3) (4) (5) (6) (7) (8) (9) . In the rat, Tannenbaum et al. (10) demonstrated that the intradermal injection ofcytoplasmic granules purified from rat peritoneal mast cells induced leukocyte infiltration with kinetics similar to those of IgE-dependent cutaneous LPRs. Additional studies by Kaliner and his associates indicated that among several rat mast cell granule-associated factors which could induce leukocyte infiltration, the most potent was a protein of 1,400 D molecular weight (3, 11, 12) . However, a review of the mediators that can be elaborated by activated mast cells reveals many that might contribute to leukocyte infiltration in LPRs, including lipid mediators such as LTB4, LTC4, LTD4, PGD2, and PAF (platelet activating factor), as well as several peptide or proteinacious chemotactic factors (13) (14) (15) . The latter agents range in size from tetrapeptide "eosinophil chemotactic factors of anaphylaxis" to very high molecular weight "neutrophil chemotactic factors" (13) (14) (15) .
Even more candidate mast cell-associated mediators ofleukocyte infiltration recently have been identified, including cy-tokines similar or identical to tumor necrosis factor-alpha (TNF-a; [16] [17] [18] [19] [20] [21] , interleukin-1 a (22) , and four members of the MIP-I gene family of small secreted peptides, T cell activation antigen 3 (TCA3), JE, and the macrophage inflammatory proteins la and I 3 (MIP-la and MIP-1If, reference 22). Four of these cytokines (TNF-a, IL-1 a, MIP-1 a, and MIP-I10) have been demonstrated to have the ability to promote leukocyte infiltration (23) (24) (25) (26) (27) (28) , whereas mouse TCA3 and JE are regarded as likely to have such activity based on their structural homology to other members of the MIP-1 gene family (29) [30] [31] [32] . Many of these cell types can produce mediators that might contribute to the initiation and/or perpetuation of LPRs. In addition, the fact that mast cell degranulation occurs before the development of the LPR does not necessarily prove that the first event is required for the second. Mast cell activation also occurs at early intervals during the development of contact hypersensitivity responses, but the magnitude of the leukocyte infiltration that develops in cutaneous contact sensitivity reactions in genetically mast cell-deficient mice equals or, in some cases, exceeds that observed in the congenic normal animals (reviewed in [33] [34] [35] . Moreover, Dolovich et al. (36) reported that the early wheal responses induced by intracutaneous injection ofcodeine were rarely followed by clinically detectable late reactions, indicating that human cutaneous mast cell activation per se may not in all cases be sufficient for production ofa LPR. Finally, three groups have reported that fatal systemic anaphylaxis can be elicited in appropriately sensitized genetically mast cell-deficient mice that are virtually devoid of mast cells (37) (38) (39) . Passive transfer studies indicate that the antibodies responsible for these reactions are of the IgE class (40) . Thus, the occurrence of mast cell degranulation and leukocyte infiltration at the same site does not prove the two events are causally related, nor does the fact that a reaction is IgE-dependent prove that the critical source of mediators in the reaction is the mast cell.
We therefore decided to evaluate directly the role of the mast cell in the development of the leukocyte infiltration associated with IgE-dependent cutaneous LPRs, by comparing the expression of these reactions in normal mice, genetically mast cell-deficient W/WV mice, and W/WU mice that had been selectively and locally repaired of their cutaneous mast cell deficiency by the injection of IL-3-dependent mast cells derived in vitro from the bone marrow cells ofthe congenic normal (+/+) mice.
Methods
Mice. Genetically mast cell-deficient mice and the congenic normal (+/+) mice (WB/ReJ-W+ x C57BL/6J-W9/+) F,4 W/WV, +/+), designated here WBB6F,-( W/WX, +/+), were purchased from the Jackson Laboratory (Bar Harbor, ME). The skin ofadult WBB6F,-W/W' mice contains < 1% the number of mast cells present in the skin of the congenic normal (+/+) mice (41, 42) . C57BL/6 mice were purchased from the Charles River Laboratories. All mice were used at 2-7 mo of age unless stated otherwise. In all experiments, tissue from sites of PCA reactions (left ears) and control sites (right ears) were obtained after sacrifice by cervical dislocation and were processed for 1-Mm Epon-embedded, Giemsa-stained sections (33, 46) . Coded sections were examined by one observer (Z.-S. Wang) who was unaware of the identity of individual sections. The number of mast cells per square millimeter of dermis was determined as previously described (7, 9) , and the mast cells were classified morphologically as extensively degranulated (2 50% of the cytoplasmic granules exhibiting fusion, staining alterations, and/or extrusion from the cell), slightly to moderately degranulated (10-50% of the granules exhibiting fusion or discharge), or normal (7, 9) . We also quantified the number ofgranulocytes present at the reaction sites, and expressed the results as the number of granulocytes per square millimeter ofdermis, as previously described (7, 9) . In all of the PCA reactions analyzed in this study, > 90% of the infiltrating leukocytes were neutrophils.
Mast cell reconstitution ofgenetically mast cell-deficient WIW" mice. WBB6F,-WIW" mice were repaired of their mast cell deficiency selectively and locally by the injection of growth factor-dependent, bone marrow-derived cultured mast cells into one ear (7, 9, 44, 47) . We reported that IL-3-dependent, bone marrow-derived, WBB6F,-+/+ mast cells maintained in suspension culture represent immature mast cells that express certain phenotypic similarities to mucosal mast cells, but that upon injection into the skin (7, 9, 44, 47) of WBB6F,-W/W" mice, these mast cell populations gradually (over a 10-wk period) acquire multiple phenotypic characteristics of the mature connective tissue-type mast cells present in the dermis of normal mice. Moreover, injection of cultured mast cells into one ear of WIW' mice repairs the mast cell deficiency in that ear alone. The mice remain mast cell-deficient at other cutaneous sites and in other organs, and remain anemic as well (7, 9, 44) . Briefly, bone marrow cells from WBB6F,-+/+ mice were grown in vitro for 3-5 wk in concanavalin A-stimulated mouse spleen cell-conditioned medium until mast cells represented > 95% of the total cells as determined by neutral red staining. Mast cells (0.5 X 106) in 20 Ml of DMEM (Gibco) were injected into the left ears and 20
Ml of medium alone into the right ears. 10 wk after injection of mast cells, IgE anti-DNP antibodies were injected into both ears and antigen challenge was performed as described above. In all experiments, we confirmed histologically that local reconstitution of dermal mast cell populations had occurred and determined that the W/W' mice locally reconstituted with mast cells remained anemic.
Assessment ofthe effects ofrabbit antiserum raised against TNF on tissue swelling or neutrophil accumulation in response to rm TNF-a or IgE-dependent reactions. In preliminary experiments, various doses of recombinant murine TNF-a (rmTNF--, Genzyme, Boston, MA) in 20
Ml of HMEM/Pipes were injected into the left ears of C57BL/6 mice and similar dilutions of normal rabbit serum (NRS) were injected into the right ears as a control. In some experiments, the left ears of mice were injected with rmTNF-a and various doses of a polyclonal rabbit antiserum raised against rmTNF-a (R anti-rmTNF-a, reference 21), whereas the right ears received rmTNF-a and similar dilutions of normal rabbit serum. The preparation and characterization of the R antirmTNF-a antiserum has been described in detail (21) . Briefly, rmTNF (Genentech, Inc., South San Francisco, CA) was reduced and alkylated with 50 mM dithiothreitol and 100 mM iodoacetate, respectively. New Zealand white rabbits were primed by intramuscular injection of 250 /ig of protein in Freund's complete adjuvant and boosted with 50 jg in Freund's incomplete adjuvant. When titered against rmTNF-a in an L929 cell cytotoxicity assay, the R anti-rmTNF-a antiserum had an activity of> 8 XI05 neutralizing U/ml (21) .
Finally, the effect of R anti-rmTNF-a was examined in IgE-dependent reactions. Mice were sensitized by injection of monoclonal IgE anti-DNP antibodies into both ears. The next day, immediately before systemic challenge with DNPx0 Q-HSA, all mice received an i.d. injection of R anti-rmTNF-a(1/100 dilution) into the left ear and the same dilution of normal rabbit serum into the right ear. Tissue swelling and neutrophil accumulation were assessed as described above.
Assessment ofendotoxin content ofreagents injected into mice. According to the limulus amebocyte lysate chromogenic assay (LAL Assay, Whitaker Bioproducts Inc., Walkersville, MD), the endotoxin content of our HMEM, IgE-containing ascites, R anti-rmTNF-a, NRS, or rmTNF-a preparations, when tested at the dilutions actually injected into the mice, ranged from 0.23 to 0.50 EU/ml (all values <0.05 ng/ ml). Based on these values and the volumes ofthe reagents injected, the amounts of endotoxin which were administered in these preparations were 1 l,000-fold below those required to elicit significant leukocyte infiltration when injected into the skin of mice (48) .
Statistical analysis. The results of ear swelling assays or differences in mast cell or granulocyte counts in different groups of mice were analyzed for statistical significance (P < 0.05) by Student's t test (twotailed); values for left and right ears in individual mice were analyzed by the paired Student's t test (two tailed).
All results are expressed as the mean±SEM.
Results
Kinetics of tissue swelling and neutrophil infiltration during IgE-dependent PCA reactions. As shown in Fig. 1 (Fig. 5) . Moreover, significant neutrophil accumulation occurred within 6 h of antigen challenge in the mast cell-reconstituted left ears, whereas the mast cell-deficient right ears exhibited little or no reaction (126±43 vs. 10±2 neutrophils/mm2 of dermis, respectively, L vs. R, P < 0.01, Fig. 6 ). These results confirm that mast cells are necessary for both the tissue swelling and the neutrophil infiltration associated with IgE-dependent cutaneous reactions in the mouse. The cutaneous neutrophil accumulation elicited by rmTNFa is inhibited by a rabbit antiserum to rmTNF-a. We first showed that the intradermal injection of40 or 400 U, but not 4 U, of rmTNF-a induced significant neutrophil accumulation within 6 h ofadministration when compared to medium alone injected into the contralateral (control) ears (Fig. 7) . We then tested the ability of our R anti-rmTNF-a antiserum to inhibit the cutaneous reaction elicited by intradermal injection of 40 U of rmTNF-a, a dose which elicited a level of neutrophil infiltration similar to that observed in the PCA reactions of normal or mast cell-reconstituted W/W' mice. The simultaneous injection into the left ear ofrmTNF-a and the antiserum (at 1:100 dilution) resulted in significantly less neutrophil accumulation at 6 h than that observed in the contralateral right ears which were injected with 40 U of rmTNF-a and a 1 :100 dilution ofNRS (18±7 vs. 1 15±15 neutrophils/mm2 ofdermis, respectively, P < 0.001). Antiserum to rmTNF-a partially inhibits the neutrophil infiltration associated with an IgE-dependent cutaneous reaction.
We next tested the effect of the R anti-rmTNF-a antiserum on the mast cell-dependent neutrophil infiltration associated with IgE-dependent PCA reactions. In these experiments, both ears of C57BL/6 mice were sensitized with IgE anti-DNP antibodies. Before systemic challenge with DNP30-40-HSA, the left ears were injected with a 1:100 dilution of R anti-rmTNF-a, whereas the right ears received a 1:100 dilution of NRS. In the experiment shown in Fig. 8 , significantly less neutrophil accumulation was seen 6 h after initiation of PCA reactions in the left (R anti-rmTNF-a-treated) ears compared to the values for the reactions in the contralateral right (NRS-treated) ears (60±19 vs. 151±37 neutrophils/mm2 dermis, respectively, P < 0.05). Similar results were seen in two other experiments; the reduction in neutrophil infiltration observed in R antirmTNF-a-as opposed to NRS-treated PCA sites in the three experiments was 47±7% (mean±SEM).
Discussion
We found that virtually all of the leukocyte infiltration associated with IgE-dependent late phase reactions in mouse skin was mast cell dependent. In accord with our previous work (44) Histological analysis indicated that leukocyte infiltration developed rapidly at sites of IgE-induced mast cell degranulation in normal mice. Some neutrophils were present as early as 2 h after antigen challenge (44, and unpublished data). How- ever, the numbers of neutrophils reached the highest levels by [6] [7] [8] [9] [10] [11] [12] h, diminished slightly by 24 h, and had waned significantly by 48 h. At all intervals analyzed, neutrophils represented > 90% of infiltrating leukocytes; the rest were primarily mononuclear cells with occasional eosinophils. Two lines of evidence indicated that the leukocyte infiltration that followed IgE-dependent PCA reactions was mast cell dependent. First, the minimal levels of neutrophil infiltration observed at IgE-injected sites of antigen challenged mast celldeficient WIW" mice were not statistically distinguishable from those observed either in the contralateral control (medium-injected) ears of these mice or in the control sites in antigen-injected congenic normal (+/+) mice (Fig. 4 B) . In addition to supporting the hypothesis that mast cells are required for expression of IgE-dependent recruitment of leukocytes to the skin, these findings are consistent with our previous work indicating that the ability ofdilute preparations ofIgE-contain- Significant differences between values for L and R ears are shown as **P < 0.02, ***P < 0.00 1.
ing ascites to elicit cutaneous inflammation reflects primarily the preparation's content of biologically active IgE (44) . Thus, heating to 560C for 1 h, which destroys the ability of IgE to bind to Fc0RI, completely abrogated the ability of IgE-containing preparations to prime skin for the expression of a PCA reaction (44) . Second, local selective repair of the mast cell deficiency of W/WV mice by injection, 10 wk before the experiment, ofbone marrow-derived cultured mast cells of congenic +/+ mouse origin permitted such sites to express both the tissue swelling response and the neutrophil infiltration associated with IgE-dependent reactions (Fig. 5 and 6 ). By contrast, neither the tissue swelling nor the leukocyte infiltration observed in the IgE-injected contralateral mast cell-deficient ears of the same mice differed significantly from those seen in non-IgE injected control sites in W/W' mice. Thus, the inability of W/WV mouse skin to express either the immediate swelling associated with IgE-dependent PCA reactions or the later infiltration of neutrophils at these sites reflected the mast cell deficiency of this tissue, not some other aspect of the Wlocus/c-kit (49) mutations of these mice. As pointed out in the Introduction, the influx of leukocytes into sites of mast cell degranulation might reflect the actions of several mast cell-derived mediators, including products ofarachidonic acid oxidation, chemotactic peptides or proteins, and/or several different cytokines. Upon activation via the FcfRI, IL-3-dependent or -independent cloned mouse mast cells have been shown to develop increased levels ofmRNA for at least six cytokines with demonstrated or potential ability to elicit leukocyte infiltration: TNF-a, IL-I a, MIP-1 a, MIP-1 , TCA3, and JE (21, 22) . IgE-dependent activation of cloned mouse mast cells also results in the release of bioactivity for TNF-a and IL-Ia (21, 22) . However, studies of cytokine production by mature, physiologically relevant mouse mast cell populations have been rather limited. Plaut et al. (50) reported that mouse peritoneal mast cells can release IL-3 upon activation via the FcERI, and we have shown that the same popula- In the present study, we demonstrated that the intradermal injection of 40 U of rmTNF-a induced an interstitial infiltration of neutrophils similar in magnitude and kinetics to that observed after IgE-dependent mast cell degranulation. We then showed that a rabbit antibody raised against rmTNF-a, which is able to inhibit completely the cytotoxicity of both rmTNF-a and connective tissue-type mast cells against L929 cells in vitro (21) , was able to inhibit by -84% the neutrophil infiltration induced by intradermal injection of rmTNF-a into mouse skin. Finally, we demonstrated that when compared to similar dilutions of NRS, rabbit anti-rmTNF-a was able to diminish significantly (by 47±7%) the neutrophil infiltration elicited in association with IgE-dependent cutaneous mast cell degranulation.
Our findings thus support the hypothesis that TNF-a contributes to the mast cell-dependent leukocyte infiltration associated with cutaneous LPRs. This result is not surprising, given the many studies demonstrating that TNF-a can promote leukocyte infiltration by effects on both vascular endothelial cells and leukocytes (reviewed in 23, 24, 53) , and our recent demonstration that mouse connective tissue-type mast cells can represent a source of both preformed and IgE-inducible TNF-a (19, 21). However, it should be noted that the anti-rmTNF-a antiserum was more effective at diminishing the leukocyte infiltration elicited by rmTNF-a (decreased by 84%) than that observed after mast cell degranulation (decreased by 47±7% in three separate experiments). One possible explanation for this difference is that the intradermally injected rmTNF-a was more accessible to the R anti-rmTNF-a than was endogenous TNF-a of mast cell origin. In mouse mast cells generated in vitro, a significant fraction of the TNF-a bioactivity is associated with the cells' cytoplasmic granules (19) . If the same is true for dermal mast cells, the physical association of TNF-a with other components of the mast cell granule may have limited access to the cytokine by R anti-rmTNF-a antibodies. Moreover, the rmTNF-a was given as a single injection, whereas mast cells activated via IgE in vitro can release TNF-a over a prolonged period after stimulation (21) .
On the other hand, given the large number of products of mast cell origin that might contribute to leukocyte infiltration, we feel that it is unlikely that mast cell-derived TNF-a would represent the sole mediator ofleukocyte infiltration in the LPR in mice. We think that it is more reasonable to propose that the leukocyte infiltration which follows IgE-dependent mast cell activation is orchestrated by several products of the mast cell, perhaps in concert with mediators from other cells that are recruited to these reactions. It should also be remembered that while mouse and human mast cells share broad similarities, they also express certain differences in mediator content (reviewed in 13, 14, 54, 55) . It is entirely possible that patterns of cytokine production in mouse and human mast cells will also be found to differ (56) . Therefore, even though the mast cellreconstituted, mast cell-deficient mouse model is very useful for identifying the roles of mast cells in biological responses in the mouse, the conclusions of such studies cannot be extrapolated uncritically to human systems.
One final point deserves brief consideration. The mast cell generally is thought to contribute to inflammation by releasing proinflammatory mediators acutely in response to immunologically specific or nonspecific stimuli (reviewed in 13-15, 20, 35, 54, 55) . However, it has been proposed that mast cells may also release very small quantities of mediators, either intermittently or over long intervals, by vesicular transport or other mechanisms (reviewed in reference 54). It is possible that such low level release of cytokines or other mast cell-associated mediators might alter the properties of the vasculature or other elements of the tissues in which mast cells reside (56) . If this indeed were the case, reconstitution of mast cell populations to the tissues of mast cell-deficient mice might influence the development of inflammatory responses both because the reconstituted tissues could express the acute effects of mast cell activation and also because of more chronic, "priming" effects of mast cells on the tissue microenvironment. Unfortunately, several technical considerations may make it difficult to quantify or even to establish the existence of such mast cell-dependent "4priming" effects in vivo. For example, there are no satisfactory techniques to ablate mast cells selectively from mast cellcontaining tissues, and it may be difficult to distinguish chronic ".priming" effects of mast cells on the tissue microenvironment from the acute effects of low levels of mast cell activation produced by the experimental manipulations of mast cell-containing tissues. As a result, at this time the existence and nature of mast cell-dependent chronic effects on vascularized tissues remain the subject of speculation.
